CapsoVision, Inc (CV) Financial Statements
Industry: Electromedical & Electrotherapeutic Apparatus
In fiscal 2025, CapsoVision reported revenue of $13.6M. Net income was -$25.3M (a -186.8% net margin), or -$1.03 per diluted share. Gross margin was 52.9% and operating margin was -188.3%. Operating activities generated -$22.9M of cash, leaving -$23.0M of free cash flow. At fiscal year end, CapsoVision held $18.2M in total assets against $4.9M in total liabilities.
Open the full interactive CapsoVision financials → Quarterly statements, key ratios, valuation history and price charts.
CapsoVision Key Stats
| Share Price | $6.78 |
|---|---|
| Market Cap | $338.6M |
| 52-Week Range | $4.59 – $14.42 |
| Shares Outstanding | 49.9 million (basic, 2026 Q2) |
CapsoVision Income Statement
| FY 2025 | |
|---|---|
| Revenue | $13.6M |
| Cost of Goods Sold | $6.4M |
| Gross Profit | $7.2M |
| Operating Income | -$25.5M |
| Pre-Tax Income | -$25.3M |
| Income Tax | $24,000 |
| Net Income | -$25.3M |
| Diluted EPS | -$1.03 |
CapsoVision Quarterly Results
| 2025 Q2 | 2025 Q3 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $3.3M | $3.5M | $2.8M | $3.6M |
| Net Income | -$4.6M | -$7.9M | -$7.0M | -$7.5M |
| Diluted EPS | -$2.02 | -$0.17 | -$0.15 | -$0.15 |
CapsoVision Balance Sheet
| FY 2025 | |
|---|---|
| Current Assets | $16.7M |
| Total Assets | $18.2M |
| Current Liabilities | $4.4M |
| Total Liabilities | $4.9M |
| Shareholders' Equity | $13.3M |
CapsoVision Cash Flow Statement
| FY 2025 | |
|---|---|
| Cash From Operations | -$22.9M |
| Cash From Investing | -$90,000 |
| Cash From Financing | $23.6M |
| Free Cash Flow | -$23.0M |
Figures from CapsoVision's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full CapsoVision financials page for every line item.
CapsoVision Company Profile
| Ticker | CV |
|---|---|
| Exchange | Nasdaq |
| Industry | Electromedical & Electrotherapeutic Apparatus |
| Headquarters | Saratoga, California |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Emerging growth company |
| SEC CIK | 0001378325 |
Frequently Asked Questions
What was CapsoVision's revenue in fiscal 2025?
CapsoVision (CV) reported revenue of $13.6M for fiscal 2025.
What was CapsoVision's net income in fiscal 2025?
CapsoVision reported net income of -$25.3M for fiscal 2025.
What was CapsoVision's earnings per share (EPS) in fiscal 2025?
CapsoVision's diluted EPS was -$1.03 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did CapsoVision generate in fiscal 2025?
CapsoVision generated -$23.0M of free cash flow in fiscal 2025.
What was CapsoVision's revenue last quarter?
In its most recent reported quarter (2026 Q2), CapsoVision reported revenue of $3.6M.
How many shares of CapsoVision are outstanding?
CapsoVision reported a weighted average of 49.9 million basic shares outstanding in 2026 Q2.
What is CapsoVision's market cap?
Based on its latest closing price, CapsoVision (CV) has a market capitalization of about $338.6M.
When does CapsoVision's fiscal year end?
CapsoVision's fiscal year end, as registered with the SEC, is December 31.
Where is CapsoVision headquartered?
CapsoVision lists its business address in Saratoga, California in its SEC filings.